View in EDS HTML Full Text PDF Full Text

The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers.

Saved in:
Bibliographic Details
Title: The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers.
Authors: Rubio-Rivas, Manuel1 (AUTHOR) mrubio@bellvitgehospital.cat, Mora-Luján, José M.1 (AUTHOR), Montero, Abelardo1 (AUTHOR), Aguilar García, Josefa Andrea2 (AUTHOR), Méndez Bailón, Manuel3 (AUTHOR), Fernández Cruz, Ana4 (AUTHOR), Oriol, Isabel5 (AUTHOR), Teigell-Muñoz, Francisco-Javier6 (AUTHOR), Dendariena Borque, Beatriz7 (AUTHOR), De la Peña Fernández, Andrés8 (AUTHOR), Fernández González, Raquel9 (AUTHOR), Gil Sánchez, Ricardo10 (AUTHOR), Fernández Fernández, Javier11 (AUTHOR), Catalán, Marta12 (AUTHOR), Cortés-Rodríguez, Begoña13 (AUTHOR), Mella Pérez, Carmen14 (AUTHOR), Montero Rivas, Lorena15 (AUTHOR), Suárez Fuentetaja, Rebeca16 (AUTHOR), Ternero Vega, Jara Eloísa17 (AUTHOR), Ena, Javier18 (AUTHOR)
Source: JGIM: Journal of General Internal Medicine. Jan2022, Vol. 37 Issue 1, p168-175. 8p. 1 Diagram, 6 Charts, 2 Graphs.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:08848734
DOI:10.1007/s11606-021-07146-0